AI assistant
Sending…
ABEONA THERAPEUTICS INC. — Director's Dealing 2021
Oct 8, 2021
33413_dirs_2021-10-08_43a18293-7db4-4e9c-b9af-b42479e1a07b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABEONA THERAPEUTICS INC. (ABEO)
CIK: 0000318306
Period of Report: 2021-10-07
Reporting Person: Wider Todd (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-07 | Common Stock | S | 25000 | $0.966 | Disposed | 0 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.9624 to $0.9661, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.
More from ABEONA THERAPEUTICS INC.
Regulatory Filings
2026
Jun 4
Interim / Quarterly Report
2026
May 13
Report Publication Announcement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 4
Major Shareholding Notification
2026
Apr 28
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 17
Board/Management Information
2026
Apr 7
Major Shareholding Notification
2026
Apr 7